Clinical Study of Chemoimmunotherapy With Fresh Frozen Plasma, High Dose Methylprednisolone and Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Methylprednisolone (Primary) ; Plasma (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 29 Aug 2012 New trial record
- 22 Aug 2012 Biomarkers information updated